Abstract:Objective To evaluate the expression of vascular endothelial growth inhibitor (VEGI) in sporadic clear cell renal cell carcinoma (CCRCC) and explore its relationships between VEGI expression,pathologic grade and tumor staging.Methods Western blot and immunohistochemical staining were used to detect the expression of VEGI in CCRCC cell line (786-O cells),CCRCC and paired normal kidney tissues.A total of 50 CCRCC cases were recruited.There were 37 males and 13 females with an average age of 53 ±12 years.The tumor sizes were ＜7 cm (n=33) and ≥7 cm (n =17).Their pathologic grades were G1 (n=14),G2 (n=22) and G3 (n=14) and pathologic stages pT1 (n=32),10 pT2 (n=10) and pT3 (n =8).Results VEGI protein was predominantly located in cytoplasm.Compared with normal kidney tissues(mean optic density (MOD) of VEGI staining:0.40 ± 0.16),it was lower in CCRCC tissues (MOD:0.11 ± 0.06,P ＜ 0.01).In addition,the positive rate of VEGI expression,the expression intensity and the MOD of VEGI protein were negatively correlated with the pathologic grade of CCRCC (r =-0.640,P ＜0.01 ; r =-0.831,P ＜ 0.01 ; r =-0.781,P ＜ 0.01 respectively).The MOD of VEGI expression in ≥7 cm tumors (MOD,0.08 ±0.04) was significantly lower than that in ＜7 cm tumors (MOD:0.12 ±0.06,P ＜ 0.05).However,there was no correlations between the VEGI protein level and age,gender and pathologic stage of patients (P ＞ 0.05).Conclusion VEGI protein is predominantly located in cytoplasm.Compared with CCRCC tissues,VEGI protein level is higher in normal ones.In consideration of negative correlations between VEGI expression,pathologic grade and tumor size,it is implied that VEGI may play a negative regulatory role in the occurrence and development of CCRCC.

Expression and significance of VEGF and PCNA in renal cell carcinoma

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Significance of Cyclin D1、Cyclin E and p21cip1 mRNA Expression in Renal Cell Carcinoma

The expression and clinical significance of Survivin and VEGF in renal cell carcinoma

Expression of Vascular Endothelial Growth Factor in Renal Cell Carcinoma and Its Clinical Implications

The correlation of VEGF expression with MVD in renal pelvic carcinoma and its clinical significance

Expressions of PTEN and VEGF in human renal cell carcinoma

The Expressions and Their Significances of CD147,matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor in Renal Cell Carcinoma

Expression of GLUT1 and VEGF in renal cell carcinomas and their clinical significance meanings

The expressions of TGFβ1 and PCNA in human renal cell carcinoma and their significance

CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.

Expression and Significance of ILK and VEGF165b in Renal Cell Carcinoma

Expression and clinical significance of Survivin and Vimentin in clear cell renal cell carcinoma

Expression and Significance of Endostatin,vegf and MVD in Renal Cell Carcinoma

Expression of vimentin in renal cell carcinoma tissue and its clinical significance

The clinical significance of vasculogenic mimicry and expression of VE-cadherin in patients with clear cell renal cell carcinoma

Expression of IGF-IR and COX-2 in Renal Cell Carcinoma and Their Relationship with Cell Proliferation

Relationship of VEGF,PCNA,Survivin and pathological grading,clinical stage of bladder cancer

Expression and Clinical Significance of MMP-10 and VEGF in Renal Cell Carcinoma

Abnormality of VHL Gene and VEGF Expression in Primary Renal Cell Carcinoma

Expression and role of vascular endothelial growth inhibitor in sporadic clear cell renal cell carcinoma